Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)

Market Cap	2.74B -43.9%
Revenue (ttm)	282.31M +22.8%
Net Income	-8.32M
EPS	-0.02
Shares Out	405.08M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.02 (0.37%)
Ex-Dividend Date	Jun 3, 2026

Volume	4,372,294
Open	6.74
Previous Close	6.77
Day's Range	6.63 - 6.76
52-Week Range	5.55 - 14.15
Beta	0.53
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHE:300942

Shenzhen Bioeasy Biotechnology Co., Ltd., together with its subsidiaries, provides rapid food safety testing reagents and instruments in China and internationally. The company offers test kits, including veterinary, melamine, mycotoxin, pesticide, adulteration, ATP, vitamin, and others; equipment, such as incubator, reader, suitcase lab, automatic pressers, and others; and materials comprising pretreatment column, certified reference, and quality control. It also provides specialized solutions, which include multi-mode precision detection, proj...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 542
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300942

Financial Performance

In 2025, SHE:300942's revenue was 263.23 million, an increase of 17.38% compared to the previous year's 224.25 million. Earnings were 13.74 million, a decrease of -19.71%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 2, 2026

Data Sources Report a data error